Compounds > fluorodopa f 18
Page last updated: 2024-08-24

fluorodopa f 18 and Basal Ganglia Diseases

fluorodopa f 18 has been researched along with Basal Ganglia Diseases in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishii, K; Ishiwata, K; Isse, K; Nakamura, M; Oda, K; Saito, T; Shimizu, T1
Goldstein, DS1
Airas, L; Marttila, RJ; Paavilainen, T; Rinne, JO; Rissanen, E; Virta, J1
Binkofski, F; Büchel, C; Gaser, C; Hagenah, J; Hedrich, K; Hilker, R; Klein, C; Pramstaller, PP; Reetz, K; Siebner, HR; Thiel, A; van Eimeren, T1
Biraben, A; Bouilleret, V; Chassoux, F; Mantzaridez, M; Ribeiro, MJ; Semah, F; Trebossen, R1
Defer, GL; Degos, JD; Malapert, D; Remy, P; Ricolfi, F; Samson, Y1

Trials

1 trial(s) available for fluorodopa f 18 and Basal Ganglia Diseases

ArticleYear
Basal ganglia involvement in temporal lobe epilepsy: a functional and morphologic study.
    Neurology, 2008, Jan-15, Volume: 70, Issue:3

    Topics: Adolescent; Adult; Basal Ganglia; Basal Ganglia Diseases; Dihydroxyphenylalanine; Dopamine; Down-Regulation; Energy Metabolism; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neostriatum; Neural Pathways; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity; Substantia Nigra

2008

Other Studies

5 other study(ies) available for fluorodopa f 18 and Basal Ganglia Diseases

ArticleYear
Neuroradiologic evidence of pre-synaptic and post-synaptic nigrostriatal dopaminergic dysfunction in idiopathic Basal Ganglia calcification: a case report.
    Journal of neuroimaging : official journal of the American Society of Neuroimaging, 2010, Volume: 20, Issue:2

    Topics: Adult; Basal Ganglia Diseases; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Humans; Radionuclide Imaging; Radiopharmaceuticals

2010
Basal ganglia involvement in temporal lobe epilepsy: a functional and morphologic study.
    Neurology, 2008, Nov-25, Volume: 71, Issue:22

    Topics: Basal Ganglia; Basal Ganglia Diseases; Dihydroxyphenylalanine; Epilepsy, Temporal Lobe; Fluorine Radioisotopes; Humans; Radionuclide Imaging; Substantia Nigra

2008
Carbon monoxide poisoning-induced nigrostriatal dopaminergic dysfunction detected using positron emission tomography (PET).
    Neurotoxicology, 2010, Volume: 31, Issue:4

    Topics: Adult; Basal Ganglia Diseases; Carbon Monoxide Poisoning; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Functional Laterality; Globus Pallidus; Humans; Magnetic Resonance Imaging; Necrosis; Nerve Fibers, Myelinated; Positron-Emission Tomography; Putamen; Raclopride; Radioligand Assay; Receptors, Dopamine D2; Substantia Nigra

2010
Morphometric fingerprint of asymptomatic Parkin and PINK1 mutation carriers in the basal ganglia.
    Neurology, 2007, Aug-28, Volume: 69, Issue:9

    Topics: Adult; Basal Ganglia Diseases; Corpus Striatum; Dihydroxyphenylalanine; DNA Mutational Analysis; Dopamine; Female; Genetic Predisposition to Disease; Genetic Testing; Genotype; Globus Pallidus; Heterozygote; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Positron-Emission Tomography; Protein Kinases; Putamen; Ubiquitin-Protein Ligases

2007
Rest tremor and extrapyramidal symptoms after midbrain haemorrhage: clinical and 18F-dopa PET evaluation.
    Journal of neurology, neurosurgery, and psychiatry, 1994, Volume: 57, Issue:8

    Topics: Adult; Basal Ganglia Diseases; Dihydroxyphenylalanine; Electromyography; Fluorine Radioisotopes; Humans; Intracranial Arteriovenous Malformations; Levodopa; Male; Mesencephalon; Posture; Rest; Rupture, Spontaneous; Subarachnoid Hemorrhage; Thalamus; Tomography, Emission-Computed; Tremor

1994